Bank of Nova Scotia Acquires 14.9% Stake in KeyCorp
By Adriano Marchese
Bank of Nova Scotia has agreed to buy a minority stake in U.S.-based financial services company KeyCorp for $2.8 billion.
The Canadian financial institution said Monday that it will pay $17.17 a share to acquire a 14.9% pro-form ownership stake in the company.
Shares of KeyCorp have edged forward in 2024, gaining 1.5% since the beginning of the year and closing on Friday at $14.61.
Scotiabank said the offer price represents an 11% premium to the volume weighted average price for the last 20 trading days.
KeyCorp, which is based out of Cleveland, Ohio, operates about roughly 1,000 branches across 15 states and has $187 billion in assets. The company offers commercial and retail banking, as well as investment advice and services.
The acquisition is expected to be completed in two stages, beginning with an initial investment of 4.9% followed by an additional investment of about 10%, and Scotiabank expects the investment to be accretive to earnings per share in the first full year following the transaction's close.
The two-part deal is expected to close in the fourth quarter of fiscal 2024, and some time in fiscal 2025.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
August 12, 2024 06:33 ET (10:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk